Cheng Du

2.7k total citations · 2 hit papers
18 papers, 2.3k citations indexed

About

Cheng Du is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Cheng Du has authored 18 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Cheng Du's work include Calpain Protease Function and Regulation (3 papers), Neuroscience and Neuropharmacology Research (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Cheng Du is often cited by papers focused on Calpain Protease Function and Regulation (3 papers), Neuroscience and Neuropharmacology Research (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Cheng Du collaborates with scholars based in China, United States and Pakistan. Cheng Du's co-authors include Dennis W. Choi, Chung Y. Hsu, Rong Hu, Cynthia A. Csernansky, Ying Wu, Xiao‐Ming Xu, Mark F. Jacquin, John W. McDonald, Tien‐Sung Lin and Tien‐Yau Luh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Cheng Du

18 papers receiving 2.2k citations

Hit Papers

Neuronal and Glial Apoptosis after Traumatic Spinal Cord ... 1997 2026 2006 2016 1997 1997 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheng Du China 10 700 660 528 383 360 18 2.3k
Shuji Watanabe Japan 25 694 1.0× 682 1.0× 372 0.7× 234 0.6× 255 0.7× 96 2.5k
Dmitriy N. Atochin United States 30 182 0.3× 864 1.3× 252 0.5× 148 0.4× 513 1.4× 84 3.4k
Xingang Li China 38 346 0.5× 1.9k 2.9× 289 0.5× 52 0.1× 81 0.2× 170 4.3k
Qianxue Chen China 35 185 0.3× 2.0k 3.0× 373 0.7× 39 0.1× 283 0.8× 237 4.5k
Jeroen F. J. Bogie Belgium 28 292 0.4× 798 1.2× 134 0.3× 91 0.2× 42 0.1× 53 2.1k
Xiao-Ping Yang United States 41 403 0.6× 1.4k 2.2× 190 0.4× 61 0.2× 208 0.6× 73 4.4k
Michael B. Tropak Canada 37 843 1.2× 1.9k 2.8× 552 1.0× 859 2.2× 26 0.1× 71 4.2k
Jing Ai China 34 106 0.2× 1.8k 2.7× 200 0.4× 104 0.3× 214 0.6× 157 3.7k
Hervé Boutin United Kingdom 34 145 0.2× 1.4k 2.1× 627 1.2× 58 0.2× 93 0.3× 75 4.2k
Mehmet Kaya Türkiye 26 75 0.1× 496 0.8× 234 0.4× 92 0.2× 118 0.3× 116 2.1k

Countries citing papers authored by Cheng Du

Since Specialization
Citations

This map shows the geographic impact of Cheng Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Du more than expected).

Fields of papers citing papers by Cheng Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Du. The network helps show where Cheng Du may publish in the future.

Co-authorship network of co-authors of Cheng Du

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng Du. A scholar is included among the top collaborators of Cheng Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng Du. Cheng Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Du, Cheng, Xinli Liu, Yi Zhao, et al.. (2022). Analysis of 5-Methylcytosine Regulators and DNA Methylation-Driven Genes in Colon Cancer. Frontiers in Cell and Developmental Biology. 9. 657092–657092. 8 indexed citations
2.
Du, Cheng, et al.. (2021). Reciprocal induction of hepatitis C virus replication and stimulation of hepatic profibrogenic cytokine release and cellular viability by YKL-40. Annals of Translational Medicine. 9(22). 1649–1649. 5 indexed citations
3.
Fu, Boshi, Cheng Du, Zhikun Wu, et al.. (2020). Analysis of DNA methylation-driven genes for predicting the prognosis of patients with colorectal cancer. Aging. 12(22). 22814–22839. 11 indexed citations
4.
Li, Danqi, Da Liu, Dandan Yue, et al.. (2019). Network pharmacology and RNA sequencing studies on triterpenoid saponins from Bupleurum chinense for the treatment of breast cancer. RSC Advances. 9(70). 41088–41098. 7 indexed citations
5.
Zhou, Chenguang, et al.. (2017). A Case Report of Isolated Bilateral Cerebral Peduncular Infarction. SHILAP Revista de lepidopterología. 2017. 1–3. 2 indexed citations
6.
Jiang, Yongfang, Hui Bao, Yan Ge, et al.. (2014). Therapeutic targeting of GSK3β enhances the Nrf2 antioxidant response and confers hepatic cytoprotection in hepatitis C. Gut. 64(1). 168–179. 77 indexed citations
7.
Jin, Feng, Cheng Du, Junyan Tao, et al.. (2013). Anti-inflammatory and anti-oxidative effects of corilagin in a rat model of acute cholestasis. BMC Gastroenterology. 13(1). 79–79. 80 indexed citations
8.
Huang, Dongqing, Jie Yang, Hui An, et al.. (2012). Platelet glycoprotein IaC807T polymorphisms and ischemic stroke in young Chinese Han population.. PubMed. 16(12). 1691–5. 6 indexed citations
9.
Du, Cheng, Yongfang Jiang, Xinqiang Xiao, & Guozhong Gong. (2012). [Hepatitis C virus strain JFH1 down-regulates expression of growth arrest and DNA damage-inducible gene 45a in human hepatoma Huh7.5.1 cells].. PubMed. 20(11). 807–10. 2 indexed citations
10.
Xiao, Xinqiang, et al.. (2011). [HCV NS5A protein down-regulates hepcidin gene expression and increases hepatic intracellular iron storage].. PubMed. 19(12). 894–7. 2 indexed citations
11.
Zhao, Hong, Wenyu Lin, Kattareeya Kumthip, et al.. (2011). A functional genomic screen reveals novel host genes that mediate interferon-alpha’s effects against hepatitis C virus. Journal of Hepatology. 56(2). 326–333. 50 indexed citations
12.
Snider, B. Joy, Cheng Du, Ling Wei, & Dennis W. Choi. (2001). Cycloheximide reduces infarct volume when administered up to 6 h after mild focal ischemia in rats. Brain Research. 917(2). 147–157. 24 indexed citations
13.
Dugan, Laura L., Dorothy M. Turetsky, Cheng Du, et al.. (1997). Carboxyfullerenes as neuroprotective agents. Proceedings of the National Academy of Sciences. 94(17). 9434–9439. 612 indexed citations breakdown →
14.
Xu, Xiao‐Ming, Rong Hu, Cheng Du, et al.. (1997). Neuronal and Glial Apoptosis after Traumatic Spinal Cord Injury. Journal of Neuroscience. 17(14). 5395–5406. 803 indexed citations breakdown →
15.
Du, Cheng, et al.. (1996). Additive neuroprotective effects of dextrorphan and cycloheximide in rats subjected to transient focal cerebral ischemia. Brain Research. 718(1-2). 233–236. 62 indexed citations
16.
Du, Cheng, Rong Hu, Chung Y. Hsu, & Dennis W. Choi. (1996). Dextrorphan Reduces Infarct Volume, Vascular Injury, and Brain Edema after Ischemic Brain Injury. Journal of Neurotrauma. 13(4). 215–222. 24 indexed citations
17.
Du, Cheng, Rong Hu, Cynthia A. Csernansky, Chung Y. Hsu, & Dennis W. Choi. (1996). Very Delayed Infarction after Mild Focal Cerebral Ischemia: A Role for Apoptosis?. Journal of Cerebral Blood Flow & Metabolism. 16(2). 195–201. 496 indexed citations
18.
Du, Cheng. (1996). Very delayed infarction after mild focal ischemia: a role for apoptosis?. Medical Entomology and Zoology. 16. 195–201. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026